Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion
Yuejie Chen(Tsinghua University), Feng Qian(Guangxi University), Michael J. Hageman(Bristol-Myers Squibb (United States)), Munir Hussain(Zhejiang Sci-Tech University), Shan Wang(Hebei Medical University), Shujing Wang(Anhui Medical University), Chengyu Liu(Yunnan University), Roy Haskell(Bristol-Myers Squibb (United States)), Kevin Stefanski(Bristol-Myers Squibb (United States)), Ching Su(Bristol-Myers Squibb (United States))
Cited by 73
Related Papers
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
|npj Precision Oncology|2024|535
Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms
|Molecular Pharmaceutics|2015|165
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131
cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a
|Proceedings of the National Academy of Sciences|2012|121
Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction
|Pharmaceutical Research|2016|114